XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 Latest Research
 Infectious Diseases
 Respiratory Medicine
  Cystic Fibrosis
 Public Health
 Clinical Trials
 Medical News
 Awards & Prizes
 Special Topics
 Odd Medical News
 World News

Last Updated: Aug 19th, 2006 - 22:18:38

Cystic Fibrosis Channel
subscribe to Cystic Fibrosis newsletter

Latest Research : Respiratory Medicine : Cystic Fibrosis

   DISCUSS   |   EMAIL   |   PRINT
New treatment for cystic fibrosis patients
Jan 19, 2006, 13:10, Reviewed by: Dr. Priya Saxena

"It gives us great hope that use of this therapy will reduce how often patients feel ill, will slow the decline of lung function over time and will help these people live longer"

Scientists have discovered a new therapy for lung problems associated with cystic fibrosis that they say may reduce the use of antibiotics.

Cystic fibrosis is a genetic disorder that causes chronic lung damage due to the build-up of excessive amounts of sticky mucus.

The treatment developed by researchers at the University of North Carolina and the University of Sydney involves inhaling a salt water aerosol solution almost twice as salty as the Atlantic Ocean, reported the online edition of BBC News.

This helps to cut damage by restoring a thin lubricant layer of water that normally coats airway surfaces, it said.

In healthy people, the water layer lining in the airways helps to clear away excess amounts of mucus by sweeping it up into the mouth where it can be swallowed.

But this water layer is missing in people with cystic fibrosis, so they are unable to prevent mucus from clogging up their lungs. Ultimately, this can lead to respiratory failure.

The new therapy works by using salt to suck water from the lung tissues out on to their surface, the researchers said.

The US team used the aerosol to treat a small group of cystic fibrosis patients. They found that it significantly improved mucus clearance, lung function and breathing symptoms.

The Australian team then applied it to another 164 patients for a longer period, almost a year. They found patients needed fewer antibiotics to treat lung infections and were more able to attend work or school.

"It gives us great hope that use of this therapy will reduce how often patients feel ill, will slow the decline of lung function over time and will help these people live longer," researcher Scott Donaldson said.

- Indo-Asian News Service

Subscribe to Cystic Fibrosis Newsletter
E-mail Address:


Related Cystic Fibrosis News

Cystic fibrosis-related diabetes is due to functional abnormalities in beta cells
No evidence for inhaled corticosteroids efficacy in cystic fibrosis
Hcp1 plays a critical role in cystic fibrosis infection
Cystic fibrosis research could benefit from multi-functional sensing tool
Loss of CFTR-mediated fluid secretion is the culprit in cystic fibrosis
New treatment for cystic fibrosis patients
Genetic variations influence cystic fibrosis' severity
How to design a better drug to treat cystic fibrosis
FDA Gives Clearance to the First Cystic Fibrosis DNA test

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page


© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us